Feedback / Questions
Sovaldi (sofosbuvir) - Gilead
odalasvir (ACH-3102) - Alexion Pharma, J&J
JNJ: Pharmaceutical Business Review
(Johnson and Johnson Ltd)
-
May 24, 2015 -
"ACH-3102 + Sofosbuvir (‘Proxy’ Study): 6-week Treatment: Final Efficacy Results"
Clinical data
•
Hepatitis C Virus
http://edge.media-server.com/m/p/7c9tc824
May 24, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.